Has Dwayne Schmidt, MD received payments from drug or device companies?

Yes. Drug and device makers reported $78,681 in general payments to Dwayne Schmidt, MD across 378 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Dwayne Schmidt, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Dwayne Schmidt, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Dwayne Schmidt, MD

Interventional Cardiology · Oklahoma City, OKNPI 1568453835

Payments from drug & device makers

$78,681in general payments, 2019–2025

Across 378 payments — averaging $208.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Siemens Medical Solutions USA, Inc.$51K
AstraZeneca$17K
Esperion Therapeutics, Inc.$3K
Medtronic$2K
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$1K
Johnson & Johnson$1K
plus $3K from 35 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Siemens Medical Solutions USA, Inc.	3	$51,265
AstraZeneca	38	$16,773
Esperion Therapeutics, Inc.	7	$3,040
Medtronic(2 entities)	20	$2,001
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	86	$1,413
Johnson & Johnson	93	$1,279
Abbott	14	$505
Philips North America LLC	3	$303
Amarin Pharma, Inc.	17	$220
Sanofi-aventis U.S. LLC	13	$207
Amgen	9	$173
Novartis	8	$144
Impulse Dynamics (USA) Inc.	2	$139
E.r. Squibb & Sons, L.L.C.	9	$135
Astellas Pharma US Inc	5	$106
Chiesi USA, Inc.	4	$91
Cvrx, Inc.	3	$88
Veryan Medical Incorporated	4	$80
Novo Nordisk	5	$71
Lundbeck LLC	4	$62
Baxter Healthcare	1	$58
Pfizer	3	$47
Kerecis Limited	2	$45
Kestra Medical Technology Services, Inc.	1	$44
Boehringer Ingelheim	2	$44
Merck	2	$36
Biotronik Inc.	2	$36
Regeneron Healthcare Solutions, Inc.	2	$28
Kowa Pharmaceuticals America, Inc.	2	$27
Shockwave Medical, Inc	1	$24
Gilead	2	$24
Endologix LLC	1	$24
Boston Scientific	2	$24
Smith+Nephew	1	$19
Angiodynamics, Inc.	1	$19
Actelion Pharmaceuticals US, Inc.	1	$18
Alnylam Pharmaceuticals Inc.	1	$18
Lexicon Pharmaceuticals, Inc.	1	$17
Irhythm Technologies, Inc.	1	$17
Bardy Diagnostics, Inc.	1	$14
Althera Pharmaceuticals LLC	1	$6

How this compares

$78,681 in reported general payments places this provider in the 85th percentile of 110 interventional cardiology providers in Oklahoma.

See all interventional cardiology providers in Oklahoma →

Medicare billing

Part B allowed, 2024

$822,265

Medicare patients

1,938

Services billed

9,314

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Oklahoma City

Naeem TahirkheliOklahoma City$8.6M
Mohammad GhaniOklahoma City$1.8M
George ChrysantOklahoma City$873K
Usman BaberOklahoma City$736K
Jeffrey SparlingOklahoma City$381K
Thomas McGarryOklahoma City$153K
Faisal LatifOklahoma City$129K
Branislav SchifferdeckerOklahoma City$121K
Mazen Abu-FadelOklahoma City$98K
Marcus SmithOklahoma City$67K

See the full list for Oklahoma →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →